<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical News Base &#187; Cell</title>
	<atom:link href="http://www.medicalnewsbase.com/tag/cell/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.medicalnewsbase.com</link>
	<description>Medical News From Around The World</description>
	<lastBuildDate>Fri, 30 Jul 2010 10:00:03 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>HemaQuest closes additional $4M to Series B financing</title>
		<link>http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing-2/</link>
		<comments>http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing-2/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 22:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business / Finance]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Epstein-Barr Virus]]></category>
		<category><![CDATA[Hematology]]></category>
		<category><![CDATA[Investment]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Sickle Cell Disease]]></category>
		<category><![CDATA[Thalassemia]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing-2/</guid>
		<description><![CDATA[HemaQuest Pharmaceuticals, a clinical stage biotechnology company developing small molecule therapeutics for sickle cell disease, beta thalassemia and EBV-related cancers, announced today the closing of an additional $4M to its Series B financing by new investor, Latterell Venture Partners. This investment brings the total Series B financing to $16M..aspx&#8221;&#62;sickle cell disease, beta thalassemia and EBV-related [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HemaQuest closes additional $4M to Series B financing</title>
		<link>http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing/</link>
		<comments>http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 16:00:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business / Finance]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Epstein-Barr Virus]]></category>
		<category><![CDATA[Hematology]]></category>
		<category><![CDATA[Investment]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Sickle Cell Disease]]></category>
		<category><![CDATA[Thalassemia]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing/</guid>
		<description><![CDATA[HemaQuest Pharmaceuticals, a clinical stage biotechnology company developing small molecule therapeutics for sickle cell disease, beta thalassemia and EBV-related cancers, announced today the closing of an additional $4M to its Series B financing by new investor, Latterell Venture Partners. This investment brings the total Series B financing to $16M..aspx&#8221;&#62;sickle cell disease, beta thalassemia and EBV-related [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/business-finance-news/hemaquest-closes-additional-4m-to-series-b-financing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study on how cellular defence systems keep themselves in check from damaging cells themselves</title>
		<link>http://www.medicalnewsbase.com/medical-science-news/study-on-how-cellular-defence-systems-keep-themselves-in-check-from-damaging-cells-themselves/</link>
		<comments>http://www.medicalnewsbase.com/medical-science-news/study-on-how-cellular-defence-systems-keep-themselves-in-check-from-damaging-cells-themselves/#comments</comments>
		<pubDate>Fri, 16 Jul 2010 10:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Medical Science]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Listeria]]></category>
		<category><![CDATA[Listeriosis]]></category>
		<category><![CDATA[Molecular Biology]]></category>
		<category><![CDATA[Nitric Oxide]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/medical-science-news/study-on-how-cellular-defence-systems-keep-themselves-in-check-from-damaging-cells-themselves/</guid>
		<description><![CDATA[When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/medical-science-news/study-on-how-cellular-defence-systems-keep-themselves-in-check-from-damaging-cells-themselves/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Exposure to cigarette smoke can alter gene expression, study finds</title>
		<link>http://www.medicalnewsbase.com/medical-science-news/exposure-to-cigarette-smoke-can-alter-gene-expression-study-finds/</link>
		<comments>http://www.medicalnewsbase.com/medical-science-news/exposure-to-cigarette-smoke-can-alter-gene-expression-study-finds/#comments</comments>
		<pubDate>Wed, 14 Jul 2010 10:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Medical Science]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[Metabolism]]></category>
		<category><![CDATA[Obesity]]></category>
		<category><![CDATA[Pregnancy]]></category>
		<category><![CDATA[Smoking]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/medical-science-news/exposure-to-cigarette-smoke-can-alter-gene-expression-study-finds/</guid>
		<description><![CDATA[In the largest study of its kind, researchers at the Southwest Foundation for Biomedical Research have found that exposure to cigarette smoke can alter gene expression &#8212; the process by which a gene&#8217;s information is converted into the structures and functions of a cell. These alterations in response to smoking appear to have a wide-ranging [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/medical-science-news/exposure-to-cigarette-smoke-can-alter-gene-expression-study-finds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Role of enzyme GSTP1-1 in progression of cancer, other diseases associated with increased cell proliferation</title>
		<link>http://www.medicalnewsbase.com/medical-science-news/role-of-enzyme-gstp1-1-in-progression-of-cancer-other-diseases-associated-with-increased-cell-proliferation/</link>
		<comments>http://www.medicalnewsbase.com/medical-science-news/role-of-enzyme-gstp1-1-in-progression-of-cancer-other-diseases-associated-with-increased-cell-proliferation/#comments</comments>
		<pubDate>Tue, 13 Jul 2010 16:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Medical Science]]></category>
		<category><![CDATA[Apoptosis]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Cell Proliferation]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Myeloid Leukemia]]></category>
		<category><![CDATA[Neutropenia]]></category>
		<category><![CDATA[Non-Small Cell Lung Cancer]]></category>
		<category><![CDATA[Ovarian Cancer]]></category>
		<category><![CDATA[Small Cell Lung Cancer]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/medical-science-news/role-of-enzyme-gstp1-1-in-progression-of-cancer-other-diseases-associated-with-increased-cell-proliferation/</guid>
		<description><![CDATA[Telik, Inc. today announced the publication of a review in the journal, Cell Death and Differentiation: Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death; http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201080a.html. This review describes recent advances in the understanding of the important role that the enzyme GSTP1-1 plays in the progression of cancer and other [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/medical-science-news/role-of-enzyme-gstp1-1-in-progression-of-cancer-other-diseases-associated-with-increased-cell-proliferation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EMBL scientists develop Fly Digital Embryo to film development of fruit fly, zebrafish&#8217;s eyes and brain</title>
		<link>http://www.medicalnewsbase.com/devices-technology-news/embl-scientists-develop-fly-digital-embryo-to-film-development-of-fruit-fly-zebrafishs-eyes-and-brain/</link>
		<comments>http://www.medicalnewsbase.com/devices-technology-news/embl-scientists-develop-fly-digital-embryo-to-film-development-of-fruit-fly-zebrafishs-eyes-and-brain/#comments</comments>
		<pubDate>Mon, 05 Jul 2010 10:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Device / Technology]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Molecular Biology]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/devices-technology-news/embl-scientists-develop-fly-digital-embryo-to-film-development-of-fruit-fly-zebrafishs-eyes-and-brain/</guid>
		<description><![CDATA[The scientists at the European Molecular Biology Laboratory in Heidelberg, Germany, who &#8216;fathered&#8217; the Digital Embryo have now given it wings, creating the Fly Digital Embryo. In work published today in Nature Methods, they were able to capture fruit fly development on film, and were the first to clearly record how a zebrafish&#8217;s eyes and [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/devices-technology-news/embl-scientists-develop-fly-digital-embryo-to-film-development-of-fruit-fly-zebrafishs-eyes-and-brain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Key mechanism present in virgin olive oil protects body against breast cancer: Researchers</title>
		<link>http://www.medicalnewsbase.com/womens-health-news/key-mechanism-present-in-virgin-olive-oil-protects-body-against-breast-cancer-researchers/</link>
		<comments>http://www.medicalnewsbase.com/womens-health-news/key-mechanism-present-in-virgin-olive-oil-protects-body-against-breast-cancer-researchers/#comments</comments>
		<pubDate>Thu, 01 Jul 2010 04:00:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Apoptosis]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Cell Proliferation]]></category>
		<category><![CDATA[Diet]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Oncogene]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/womens-health-news/key-mechanism-present-in-virgin-olive-oil-protects-body-against-breast-cancer-researchers/</guid>
		<description><![CDATA[Researchers at Universitat Autònoma de Barcelona, led by Dr Eduard Escrich, have discovered a key mechanism by which virgin olive oil, in contrast to other vegetable oils, protects the body against breast cancer..aspx&#8221;&#62;breast cancer. The UAB researchers have decoded a complete cascade of signals within breast tumour cells activated by virgin olive oil, and have [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/womens-health-news/key-mechanism-present-in-virgin-olive-oil-protects-body-against-breast-cancer-researchers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Phase I study results of Pharmacyclics&#8217; PCI-32765 Btk inhibitor for B cell NHL presented at ASCO</title>
		<link>http://www.medicalnewsbase.com/uncategorized/phase-i-study-results-of-pharmacyclics-pci-32765-btk-inhibitor-for-b-cell-nhl-presented-at-asco/</link>
		<comments>http://www.medicalnewsbase.com/uncategorized/phase-i-study-results-of-pharmacyclics-pci-32765-btk-inhibitor-for-b-cell-nhl-presented-at-asco/#comments</comments>
		<pubDate>Mon, 07 Jun 2010 10:00:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Apoptosis]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Chronic Lymphocytic Leukemia]]></category>
		<category><![CDATA[Hodgkin's Lymphoma]]></category>
		<category><![CDATA[Hypersensitivity]]></category>
		<category><![CDATA[Kinase Inhibitor]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[Lymphoma]]></category>
		<category><![CDATA[Neutropenia]]></category>
		<category><![CDATA[Non-Hodgkin's Lymphoma]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Weight Loss]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/uncategorized/phase-i-study-results-of-pharmacyclics-pci-32765-btk-inhibitor-for-b-cell-nhl-presented-at-asco/</guid>
		<description><![CDATA[Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton&#8217;s tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin&#8217;s lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/uncategorized/phase-i-study-results-of-pharmacyclics-pci-32765-btk-inhibitor-for-b-cell-nhl-presented-at-asco/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ascenta Therapeutics, sanofi-aventis sign global licensing agreement for cancer drug candidates</title>
		<link>http://www.medicalnewsbase.com/business-finance-news/ascenta-therapeutics-sanofi-aventis-sign-global-licensing-agreement-for-cancer-drug-candidates/</link>
		<comments>http://www.medicalnewsbase.com/business-finance-news/ascenta-therapeutics-sanofi-aventis-sign-global-licensing-agreement-for-cancer-drug-candidates/#comments</comments>
		<pubDate>Fri, 04 Jun 2010 16:00:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business / Finance]]></category>
		<category><![CDATA[Apoptosis]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[p53 Protein]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/business-finance-news/ascenta-therapeutics-sanofi-aventis-sign-global-licensing-agreement-for-cancer-drug-candidates/</guid>
		<description><![CDATA[Ascenta Therapeutics announced today the signing of a global collaboration and licensing agreement with sanofi-aventis covering several early-stage agents being investigated for their potential to restore tumor cell apoptosis (programmed cell death). These orally-active, small-molecule drug candidates inhibit the interaction between HDM2 (Human Double Minute 2) and p53, removing a block to normal p53 tumor [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/business-finance-news/ascenta-therapeutics-sanofi-aventis-sign-global-licensing-agreement-for-cancer-drug-candidates/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AFFiRiS to explore ProBioGen&#8217;s HuALN technology for AFFITOME-based vaccination concept</title>
		<link>http://www.medicalnewsbase.com/devices-technology-news/affiris-to-explore-probiogens-hualn-technology-for-affitome-based-vaccination-concept/</link>
		<comments>http://www.medicalnewsbase.com/devices-technology-news/affiris-to-explore-probiogens-hualn-technology-for-affitome-based-vaccination-concept/#comments</comments>
		<pubDate>Wed, 02 Jun 2010 10:00:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Device / Technology]]></category>
		<category><![CDATA[Alzheimer's Disease]]></category>
		<category><![CDATA[Atherosclerosis]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Flow Cytometry]]></category>
		<category><![CDATA[Parkinson's Disease]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://www.medicalnewsbase.com/devices-technology-news/affiris-to-explore-probiogens-hualn-technology-for-affitome-based-vaccination-concept/</guid>
		<description><![CDATA[AFFiRiS AG will explore ProBioGen&#8217;s proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for its AFFITOME®-based vaccination concept. Under the contract with ProBioGen, AFFiRiS will evaluate the HuALN technology as a human organoid model to investigate drug-related effects in the context of the human immune system in order to select vaccine candidates best [...]]]></description>
		<wfw:commentRss>http://www.medicalnewsbase.com/devices-technology-news/affiris-to-explore-probiogens-hualn-technology-for-affitome-based-vaccination-concept/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
